Bactiquant A/S (9JX) Stock Price & News

All values in DKK	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	2.10M	2.10M	2.66M	2.66M
Cost of goods sold	2.76M	2.76M	2.34M	2.34M
Cost of revenue	2.76M	2.76M	2.34M	2.34M
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	1.98M	1.98M	2.16M	2.16M
Operating expense	2.40M	2.40M	2.54M	2.54M
Total operating expenses	5.17M	5.17M	4.88M	4.88M
Operating income	-3.07M	-3.07M	-2.22M	-2.22M
Other non operating income	-	-	-	-
EBT including unusual items	-3.45M	-3.45M	-2.39M	-2.39M
EBT excluding unusual items	-3.45M	-3.45M	-2.39M	-2.39M
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-3.45M	-3.45M	-2.39M	-2.39M
Net profit margin	-163.85%	-163.85%	-89.71%	-89.71%
Earnings per share	-	-	-	-
Interest and investment income	27.48K	27.48K	53.33K	53.33K
Interest expense	-407.50K	-407.50K	-227.22K	-227.22K
Net interest expenses	-380.02K	-380.02K	-173.89K	-173.89K
Depreciation and amortization charges	407.77K	407.77K	382.11K	382.11K
EBITDA	-2.85M	-2.94M	-1.83M	-1.83M
Gain or loss from assets sale	-	-	-	-

Finance